載入...
Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry
BACKGROUND: Ticagrelor is a P2Y(12) receptor inhibitor with superior clinical efficacy compared with clopidogrel. However, it is associated with reduced efficacy when combined with a high‐dose aspirin. METHODS AND RESULTS: Patients in the acute coronary treatment and intervention outcomes network (A...
Na minha lista:
| 發表在: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6220549/ https://ncbi.nlm.nih.gov/pubmed/29886424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.008125 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|